Key points interpretation of 2024 Kidney Disease:Improving Global Outcomes(KDIGO)clinical practice guideline for the evaluation and management of chronic kidney disease
The Kidney Disease:Improving Global Outcomes(KDIGO)Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease was originally published in 2012,which assists practitioners in clinical diagno-sis,prevention and treatment of chronic kidney disease(CKD).In recent years,a large number of evidence-based medical evidence has been emerging in the field of CKD.After 12 years,the work group has updated the guidelines,mainly involving the evaluation of CKD,risk assessment in people with CKD,management to delay CKD progression and manage its complica-tions,medical management and drug stewardship in CKD,and optimal models of CKD care.This article interprets the key points of the 2024 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD.
Chronic kidney diseaseEvaluationManagementThe Kidney Disease:Improving Global OutcomesGuideline